EMMAW
Emmaus Life Sciences, Inc. [EMMAW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
EMMAW Stock Summary
In the News
EMMAW Financial details
Company Rating
-
Market Cap
0
Income
-15.95M
Revenue
20.61M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
12 Aug 2019
P/E
-201.08
Forward P/E
-
PEG
1.3
P/S
-
P/B
-149.48
P/C
-
P/FCF
-
Quick Ratio
0.09
Current Ratio
0.25
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.32
EPS next Y
-
EPS next Q
-
EPS this Y
-1534.98%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
17.98%
Revenue last 5Y
176.08%
Revenue Q/Q
-47.62%
EPS Q/Q
118.75%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-28%
ROE
119%
ROC
-0.65%
Gross Margin
84%
Oper. Margin
-62%
Profit Margin
-77%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0725-0.0725
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- CEO None
- Headquarters US
- IPO Date 2021-09-16
